Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
770 USD | -0.15% | +1.32% | +32.09% |
May. 17 | Roche: share price stands out, Deutsche Bank in support | CF |
May. 16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
Evolution of the average Target Price on Eli Lilly and Company
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Eli Lilly and Company
Argus | |
Redburn Atlantic | |
China International Capital | |
JPMorgan Chase | |
Wolfe Research | |
Barclays | |
BMO Capital | |
Leerink Partners | |
Deutsche Bank Securities | |
Truist Securities | |
Goldman Sachs | |
Wells Fargo Securities | |
Morgan Stanley | |
Jefferies & Co. | |
UBS | |
BofA Securities | |
DZ Bank | |
JEFFERIES | Akash Tewari |
Cantor Fitzgerald | |
Morningstar | |
Guggenheim | |
Daiwa Securities | |
Berenberg Bank | |
Citigroup | |
Credit Suisse | |
HSBC | |
TD Cowen | |
SVB Securities LLC | |
Cowen | |
Mizuho Securities |
EPS Revisions
- Stock Market
- Equities
- LLY Stock
- Consensus Eli Lilly and Company